ARTICLE | Distillery Therapeutics
Neurology
February 8, 2017 6:59 PM UTC
In vitro and mouse studies identified an acrylic acid-based agonist of the TREK-1 potassium channel that could help treat pain. Chemical synthesis of analogs of a dihydroxyphenylacrylic acid and testi...
BCIQ Target Profiles